Doctors want liability shield from AI mistakes

The rapid deployment of artificial intelligence in hospitals and clinics is leading the nation's biggest physicians group to lobby for new legal protections if AI harms patients. Why it matters: The use of increasingly sophisticated AI tools and recommendations is blurring the lines around negligence in health care, raising questions about whether doctors should be held responsible for decisions that rely on software. There's added urgency as autonomous AI takes on more and more important medical tasks with less direct oversight. The question is who's responsible when something goes wrong. Driving the news: The American Medical Association this week called for federal and state legislation to protect physicians from liability when AI products injure patients, despite physicians using the tools as intended. The group also is pressing for new laws mandating that AI companies carry adequate liability insurance and disclose product limitations and performance data. Hospitals, health systems, insurers and health tech vendors should be responsible if the required use of specific AI products results in harmful errors, the AMA policy states. Between the lines: The group's push comes as AI clinical tools are flooding the health system, unlocking new efficiencies but giving algorithms increasing power to make decisions like whether to order a diagnostic test or prescribe an expensive drug. Legal and medical experts point to the possibility of triage errors, in which AI systems that process clinical histories, vital signs and imaging can misjudge the severity of a case without the attending doctor's knowledge. The AMA also raises the possibility of an AI system making a plausible recommendation for treatment, but with incomplete laboratory results or an outdated diagnoses. In such cases, a physician may be unable to verify the inputs. In cases where a patient is harmed, responsibility should fall on AI manufacturers and vendors — and possibly on health systems that require the
Read the full story at Axios →